肉毒毒素A和B用于棕植物性过
Trond Eilertsen1, Bjørn Øivind Kvammen2,3, Øystein Grimstad2,3
1Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway. tre025@post.uit.no.
Dermatology and therapy
|February 29, 2024
概括
肉毒素A (BTX-A) 和肉毒素B (BTX-B) 注射显著改善了手掌植物性过症患者的生活质量. 过度出汗减少了,提高了患者报告的结果.
科学领域:
- 皮肤病学 皮肤病学
- 神经学 神经学
- 生活质量研究 研究 生命质量研究
背景情况:
- 过是与温度无关的过度出汗,对生活质量产生负面影响.
- Palmoplantar 过会影响手和脚,造成严重的痛苦.
研究的目的:
- 评估肉毒素A (BTX-A) 和肉毒素B (BTX-B) 在治疗棕植物性水症中的有效性.
- 评估这些治疗对患者报告的生活质量结果的影响.
主要方法:
- 35名患有手掌和/或脚掌透症的患者接受了BTX-A或BTX-B的治疗.
- 给手掌和脚施加了特定的剂量,并采取了预防措施以避免肌肉衰弱.
主要成果:
- 皮肤病生活质量指数 (DLQI) 显著改善.
- 患者报告的结果显示,治疗后的生活质量得到了显著改善.
结论:
- BTX-A和BTX-B是有效的治疗手掌植物性水.
- 用肉毒毒素治疗导致受影响个体的生活质量显著改善.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
680
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
680
Skeletal Muscle Relaxants: Therapeutic Uses
482
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
482
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
420
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
420
Depolarizing Blockers: Pharmocokinetics
325
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
325
Depolarizing Blockers: Mechanism of Action
1.6K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
1.6K
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
1.8K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
1.8K


